SEC Enforcement Update: SEC and FDA Formalize Information-Sharing Framework
By Liz Dunshee If you’re leading a publicly traded life sciences company, you are likely well aware of the complexities of navigating multiple regulators, with the Securities and Exchange Commission and the Food and Drug Administration playing major roles in the US. Those agencies don’t operate in a vacuum. The […]
Securities Class Action Trends: AI Filings Surge, Alleged Losses and Settlement Values Climb
By Liz Dunshee Here’s the intro from a recent Securities Litigation + Enforcement alert penned by our Cooley colleagues Tijana Brien, Brett De Jarnette, Brian French and Bingxin Wu: Two leading consulting and expert firms – Cornerstone Research and the National Economic Research Associates (NERA) – recently released reports on securities class action filings […]
CapitalXchange Audio – Post-IPO Changes to Governance Structures and Board Composition
By Liz Dunshee For our latest CapitalXchange interview, I spoke with Cooley lawyers Michael Mencher and Vince Flynn about Cooley’s Post-IPO Governance Trends Report. We covered: Listen here: Show notes: The views expressed during interviews are the speakers’ personal views and do not necessarily reflect those of Cooley or any […]